Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

Intravenous lidocaine seems safe for reducing pain among patients in the intensive care unit with varying degrees of organ dysfunction

Intravenous Lidocaine Offers Alternative for ICU Patients’ Pain

0
Findings in patients in intensive care unit with varying degrees of organ dysfunction
In response to revised osteoporosis recommendations in 2008

Shift in Bisphosphonate Tx After 2008 Recommendations

0
From 2008 to 2012, drop in proportion of younger women, increase in women aged ≥65 years
For patients with type 2 diabetes

Novel Oral Glucose Lowering Drugs Cut Risks in T2DM

0
Reduced risk of all-cause mortality and CVD with dapagliflozin; lower risk of mortality with DPP-4i
For patients with Clostridium difficile infection

30-day Mortality Down With Vancomycin in C. difficile

0
But Clostridium difficile recurrence rate similar for metronidazole, vancomycin
Prescribing practices vary among U.S. and Canadian physicians treating severe childhood atopic dermatitis

Variation in Prescribing Practices for Pediatric Atopic Dermatitis

0
For severe AD, first-line drugs of choice include cyclosporine, methotrexate, mycophenolate mofetil
Adjuvant endocrine therapy can reduce the likelihood that women diagnosed with certain breast cancers will experience a recurrence of their disease

Underuse, Misuse of Hormone Tx in Breast Cancer Still Occurring

0
Estimated 14,630 women not given recommended therapy died from cancer recurrence from 2004-2013
For select patients

Psychostimulants May Be Helpful in Treatment of Bulimia Nervosa

0
Case reports highlight six outpatients with reduction in number of binge/purge days/month
The risk of cardiopulmonary adverse events is similar for propofol sedation and traditional sedation agents for gastrointestinal endoscopic procedures

Review: Cardiopulmonary Event Rate Not Up With Propofol Use

0
Similar risk with propofol versus traditional sedation for gastrointestinal endoscopic procedures
For patients treated with alirocumab

Very Low LDL-C Levels Well Tolerated With Alirocumab

0
No increase in treatment-emergent adverse event rates, neurocognitive events with low levels LDL-C
For patients with type 2 diabetes mellitus

Economic Benefit for Combo Statin/TG-Specific Tx in T2DM

0
Greatest cost reduction for statin/TG-specific-treated patients with TG level drop of ≥30 percent